To this end, a team of researchers developed a nanocomplex from MSNPs with cetuximab (an epidermal growth factor receptor targeting antibody) and used it on pancreatic cancer cell line to explore its potential use for PDT, as well as cellular uptake and ROS production. This evidence concerns the gene EGFR and pancreatic neoplasm.